"Celsion Corp. has an analyst consensus of Strong Buy, with a price target consensus of $7.
The company has a one year high of $3.73 and a one year low of $2.15. Currently, Celsion Corp. has an average volume of 258.6k"".
sw air has never experienced a disaster plane crash
clsn crashed and burned jan 31, 2013
ceo was rewarded with subsequent pay increase
true somehow.....time to give us some real news!
go on CLSN!
Sentiment: Strong Buy
Who would you say is overpaid ?
CLSN CEO has delivered very little to shareholders but take a massive salary.
I think more positive update on RCS study - this keeps bumping it up only to go down. RCW looks like a sure thing.
If China approval - wouldn't this go up exponentially in a heartbeat? What are your thoughts on to what share price would do.
BioLargo (BLGO) and Lockheed (LMT) have proven and game changing technologies to help create abundant water for everyone.
BioLargo’s breakthrough AOS Filter has been proven to decontaminate and disinfect water at unprecedented levels and speeds and cost 1/20th of the closest competing technology.
The AOS Filter is showcasing this August at the University of Alberta to huge industry leaders and is extremely close to commercialization while Lockheed’s Graphene Filter is about 3 to 5 years away.
To read report, copy and paste: Desalination Industry Screams for Cost Cutting Innovation: Lockheed And BioLargo Hold Key Technologies
BioLargo is Strong Buy with $3.00 12-month Price Target and significantly higher in coming years.
Sentiment: Strong Buy
jan 31, 2013 volume 9,359,800 closing price $6.80
jan 30, 2013 volume 627,900 closing price $36.13
did you wisely sell jan 30, 2013?
you were warned, did you wisely listen?
today price? lower than jan 31, 2013
$1.90s or $3.00 next?
insiders buying large quantities on open market?
OK so please show me where the insiders i.e. management has ever sold? I see one sell of a beneficial owner which was an automatic sell by EGWU, INC. FKA EGEN, INC which is not management, all other activity has only been buys/options granted. If you were really around for as long as you say what other ID did you use since this one is not recognized by me and I have actually been around as long or longer than you claim to have been. the only thing you post that is factual is yes we got chunged on the prolieve deal and if you really have been around you'd know what I mean by "chunged".... provide more detail else you are just another flying monkey imho.
Also sounds like China wants TDox available for use in some fashion, per CEO's comments
Look for a partner announcement for TheraSilence, their study was co-funded 50/50 with BP. Also, ThermoDox will start bringing in revenue, now, for the early access program for chest wall cancers in the EU. The stuff works.
I read today's press release and have suddenly been given hope for a new beginning.
To be truthful, it's my opinion that Thermodox, even if successful is too little too late to get us me back (at least financially) to where I first started believing in this company- and I've been around for a long a long time. I first got in to Celsion when the company symbol was CLN and they were working on a new technology for the treatment of BPH (benign enlarged prostate) called PROLIEVE. It was a huge success but due to a series of blunders by then management, the shareholders got hosed royally and our reward never materialized. Instead the company funneled the proceeds along with multiple secondary dilutions into the development of Thermodox, including one VERY expensive and time consuming clinical trial that FAILED. What a tragic waste of time and money. While I do like the determination of the board and its charges with their persistence of vision, I must be honest, I've been wishing and hoping for some time that a new "vehicle" would emerge that might hold as much promise as T-dox originally did (and perhaps still may). Todays news could actually be the first rumblings of a "Phoenix from the Ashes" and Im hopeful that we will hear more good news regarding this break thru acquisition and its novel approach in dealing with pulmonary arterial hypertension, a widespread condition for which to date, doctors have only treated superficially.
On another note, it's also encouragement of some note that management, after being sellers for nearly a decade, have begun the process of slowly purchasing shares behind the scenes- in what appears to be unmotivated actions - until today. Now we know.
So, without further ado, I will tell you all: IM BACK IN and recommend that anyone who ever believed in this company give it at least a few of your "vegas" dollars in what may prove to be a VERY handsome return (if preliminary observations prove to be repeatable).
Sentiment: Strong Buy